Equity Details
Price & Market Data
Price: $9.60
Daily Change: +$0.10 / 1.04%
Daily Range: $9.60 - $9.60
Market Cap: $3,382,036,480
Daily Volume: 100
Performance Metrics
1 Week: -11.05%
1 Month: -11.05%
3 Months: -33.43%
6 Months: -5.00%
1 Year: -84.58%
YTD: -33.43%
About Zealand Pharma A/S (ZLDPY)
Discover the market dynamics of Zealand Pharma A/S (ZLDPY). The stock stands at 9.60, with its daily performance showing a change of +$0.10 / 1.04%. Its market cap is valued at 3,382,036,480. Explore its 6-month (-5.00%) and 1-week (-11.05%) performance for a quick overview.
Details
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.